Exploring the Role of Bergamot Polyphenols in Alleviating Morphine-Induced Hyperalgesia and Tolerance through

Sara Ilari1, Saverio Nucera2, Lucia Carmela Passacatini1

  • 1IRCCS San Raffaele Roma, 00166 Rome, Italy.

Nutrients
|August 29, 2024
PubMed

Insights

Repeated morphine use causes pain tolerance and oxidative stress by affecting mitochondrial proteins. Bergamot polyphenol fraction (BPF) and MnTBAP reversed these effects, offering potential therapeutic strategies.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Morphine is a key analgesic, but its long-term use leads to tolerance and oxidative stress.
  • Oxidative stress, driven by reactive oxygen species (ROS), impairs mitochondrial function.
  • Sirtuin 3 (SIRT3) is a mitochondrial protein crucial for regulating ROS via antioxidant enzymes like manganese superoxide dismutase (MnSOD).

Purpose of the Study:

  • To investigate SIRT3's role in morphine-induced hyperalgesia and tolerance.
  • To evaluate the antioxidant effects of bergamot polyphenol fraction (BPF) in mitigating morphine's side effects.

Main Methods:

  • Mice received repeated morphine doses, followed by acute morphine with or without BPF or MnTBAP.
  • Assessed spinal cord levels of malondialdehyde (MDA), nitration, and the activity of SIRT3, MnSOD, glutamine synthetase (GS), and glutamate 1 transporter (GLT1).

Main Results:

  • Repeated morphine administration induced antinociceptive tolerance and increased oxidative stress markers.
  • Morphine treatment led to decreased activity of mitochondrial SIRT3, MnSOD, GS, and GLT1.
  • Co-administration of BPF or MnTBAP with morphine prevented tolerance and normalized oxidative stress markers and enzyme activities.

Conclusions:

  • SIRT3 plays a critical role in the development of morphine tolerance and hyperalgesia.
  • BPF exhibits antioxidant properties that counteract morphine-induced oxidative stress and tolerance.
  • Targeting SIRT3 and oxidative stress pathways may offer new therapeutic avenues for managing pain and mitigating opioid side effects.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
251
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
589
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
156